Nocturnal ads

It was just a matter of time for the first class-action lawsuit targeting Oura's tracking accuracy claims. The case alleges that Oura overstated its sleep-tracking accuracy by presenting a roughly 95% sleep/wake-detection figure as “sleep staging accuracy,” although Oura itself says four-stage performance is closer to 76–79%. Class-action suits are notorious for overstating their own claims, most likely ending in a settlement that enrich the litigating lawyers with marginal contribution to consumers. ⚠️ ⚠️⚠️Yet, it's another warning sign for MedTech companies tempted to go the consumer-wellness route to avoid the regulatory scrutiny that comes with a clinical device. ⚠️ ⚠️⚠️ Pursuing a clinical outcome unquestionably raises the burden of proof. Intended use, risk analysis, verification, clinical validation and regulatory evidence all become more demanding. But that evidence can also become a strategic asset. The therapy, patient-response data and ability to refine treatment can create a proprietary therapy–data loop and a much stronger moat. This doesn’t mean every wearable should become a medical device. It means the consumer route should not be selected simply because it appears easier. ➡️ The Next Wearables Frontier - https://lnkd.in/eS_VtciD/?utm_campaign=Biz/Funding/Pricingposts&utm_source=linkedin&utm_medium=paid&utm_id=727780104&hsa_acc=511527263&hsa_cam=727780104&hsa_grp=351802734&hsa_ad=1563243754&hsa_net=linkedin&hsa_ver=3

Reliable signal acquisition is essential, but it’s only step one. How signal data is processed and analyzed determines whether it can ultimately support your algorithm development, product verification, and regulatory submission. Hidden issues can make device datasets difficult to compare and weaken the evidence needed for development and regulatory decisions: - Inaccurate synchronization - Over-conditioning - Incompatible sources of truth - Missing context These problems are especially costly when discovered late, which could mean reprocessing data in the best case, or collecting a new datasets in the worst case scenario. Our latest article examines five common medical device data traps and how to avoid them. Check it out here - https://lnkd.in/g8ABPjhj/?utm_campaign=Biz/Funding/Pricingposts&utm_source=linkedin&utm_medium=paid&utm_id=727780104&hsa_acc=511527263&hsa_cam=727780104&hsa_grp=351802734&hsa_ad=1560173524&hsa_net=linkedin&hsa_ver=3 #MedicalDevice #Biosignal #DataScience

Neurotechnology is a hot space right now, with a lot of promising innovation. When we start diving with founders into their technology, there is often an AHA! moment. The hardware, the firmware, the power management, the system architecture — these all have a lot in common from one implant to the next. There are plenty of devices with a pulse generator that listens to bio-signals and delivers a controlled pulse to the human body. That's actually good news. This is not easy stuff. Putting something in the human body takes real expertise. But it's expertise that already exists. The parts that may feel most daunting to you are well understood to a team with the right track record. What's really unique to your innovation? It's most likely things like: 📍 Your physiologic target 📍 Your stimulation sequence 📍 Your algorithm That's your competitive moat. Where you spend your innovation budget is a critical strategic decision. Don't reinvent the hard parts that others have already mastered. See how we can help: https://lnkd.in/eZ7snhtC//?utm_source=linkedin&utm_medium=paid&utm_id=727780104&utm_campaign=Biz/Funding/Pricingposts&hsa_acc=511527263&hsa_cam=727780104&hsa_grp=351802734&hsa_ad=1508313564&hsa_net=linkedin&hsa_ver=3

Experienced medical device pros are often surprised when they hear we do fixed-priced projects. There are good reasons fixed-cost pricing is a rarity in this field. Development of Class II and Class III devices is a highly complex undertaking. It lasts years, not months. Going into it, there are many unknowns. Initial assumptions often need to be reassessed as the project unfolds. So how does Nocturnal make fixed-cost projects work? Take a peek behind the scene and learn the secrets to navigating fixed-cost projects in medical device development - https://lnkd.in/eySFWv5G

The data is out for H1 MedTech venture funding. 😁 The good news: After a steady multiyear decline, the number of early-stage deals is on pace with 2025 (62 Seed and Series A deals in H1 vs. 132 in 2025). 🤢 The not so good news: Pretty much everything else. ↘️ Overall number of deals is trending ~11% lower compared to 2025. ↘️ Overall investment run rate across all rounds is about 20% lower than 2025. Most concerning for early-stage startups: ↘️ Average deal size for Seed and Series A rounds is down 15%, putting additional pressure on startup teams to deliver quick results with a shorter runway. In today’s MedTech funding environment, capital efficiency is the driving factor. It means making every design, development, testing, and data collection decision serve the next proof point investors need to see. Get the guide that walks you through these disciplines: https://lnkd.in/esyt9ehk//?utm_source=linkedin&utm_medium=paid&utm_id=727780104&utm_campaign=Biz/Funding/Pricingposts&hsa_acc=511527263&hsa_cam=727780104&hsa_grp=351802734&hsa_ad=1476697894&hsa_net=linkedin&hsa_ver=3

Neuromodulation presents one of the strongest use cases for the next generation of wearables. Unlike drugs, which often act systemically, neuromodulation can target specific nerves, muscles, or physiological pathways. The therapy can be adjusted based on patient response, reduced or stopped when needed, and paired with real-time data to support increasingly personalized treatment. Better understanding of neural circuits, combined with smaller electronics, lower-power components, improved batteries, and more capable sensing, is making these systems increasingly practical across multiple therapeutic targets, including: • Chronic pain • Migraine and headache disorders • Overactive bladder and pelvic health • Movement disorders and epilepsy • Respiratory and sleep-related conditions Read more about the next wearables frontier: https://lnkd.in/d273xH4x #Neuromodulation #Wearables #MedicalDevices #MedTech #Neurotechnology